Salarius Pharmaceuticals Inc (NASDAQ:SLRX) traded at $1.08 at close of the session on Friday, June 20 and made an upward move of 1.15% on its previous day’s price.
Looking at the stock we see that its previous close was $26.00 and the beta (5Y monthly) reads 0.379 with the day’s price range being $1.0 – $1.33. In terms of its 52-week price range, SLRX has a high of $7.20 and a low of $0.45. The company’s stock has gained about 46.45% over that past 30 days.
Salarius Pharmaceuticals Inc has a market cap of $2.45 million and is expected to release its quarterly earnings report on 2025-Mar-21.
Looking further, we note the current price level is 2 off its SMA20 and 0.00 from its 50-day simple moving average. The beta value is -96.98%, while the average true range (ATR) is currently pointing at -99.68%.
Coming back to Salarius Pharmaceuticals Inc (NASDAQ:SLRX), we note that the average 3-month trading volume was 1.07, while that of the preceding 10-day period stands at 6.89 million. Current shares outstanding are 2.13 million.
The insiders hold 0.68% of the company’s shares while institutions hold 3.02%. The data shows that short shares as of 2025-05-30, stood at 47988.0 at a short ratio of 1.67. This represents a 227.00 short interest in shares outstanding on 2025-05-30. Shares short fall in May from the previous month at 84158.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -66.95% down in year-to-date price movement.
